Phebra Pty Ltd

Privately held: no public share price · Australia

Assets

(1 total)
1Total Assets
1Approved
0Phase 3 / Filed
0Phase 1–2 / Early
1Diseases
Showing 1 of 1 assets
Target & Modality
Approved
Glutathione precursor (cysteine donor)Small molecule
Toxicology / Acetaminophen Overdose
Acetaminophen Overdose

Upcoming events

No upcoming trial completions or earnings dates on record for this company's assets.

Regulatory and conference events

(1)

Filings, regulator decisions, scientific presentations, topline results and licensing deals, each from a dated source. When a source gives only the month, the month is shown.

Recent

9 December 2024ApprovalN-acetylcysteineFDA approves Acetadote sNDA for simplified dosing regimen
US, FDA · Source ↗

Financial reports

No financial reports recorded.